Laptm5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| LAPTM5 - Lysosomal associated transmembrane protein 5 | |
|---|---|
| Gene Symbol | LAPTM5 |
| Full Name | Lysosomal associated transmembrane protein 5 |
| Chromosomal Location | 1p35.1 |
| NCBI Gene ID | 57143 |
| OMIM | 605365 |
| Ensembl ID | ENSG00000125351 |
| UniProt ID | Q9Y5W7 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Hematological malignancies |
| Protein | LAPTM5 Protein |
The LAPTM5 (Lysosomal Associated Transmembrane Protein 5) gene encodes a multi-pass membrane protein primarily localized to lysosomes and the endoplasmic reticulum. LAPTM5 is a member of the LAPTM family of proteins that play critical roles in lysosomal function, autophagy regulation, and cellular homeostasis. The gene is expressed at high levels in immune cells and various brain regions, where it supports lysosomal trafficking, autophagy, and neuronal survival.
The LAPTM5 gene spans approximately 12 kb on chromosome 1p35.1 and consists of multiple exons. The gene encodes a protein of approximately 397 amino acids with multiple transmembrane domains. Key features include:
LAPTM5 is essential for proper lysosomal trafficking and function. The protein interacts with components of the lysosomal trafficking machinery, including:
LAPTM5 plays a crucial role in the autophagy-lysosome pathway:
In hematopoietic cells, LAPTM5 expression is particularly high and regulates:
In the central nervous system, LAPTM5 supports:
LAPTM5 shows tissue-specific expression:
LAPTM5 dysregulation contributes to Alzheimer's disease pathogenesis:
Autophagy-lysosome pathway impairment: Reduced LAPTM5 expression in AD brains leads to defective autophagic flux, accumulating autophagic vacuoles and reducing clearance of amyloid-beta peptides[2]
Lysosomal membrane permeabilization: Altered LAPTM5 function increases lysosomal vulnerability to stress, releasing cathepsins that activate apoptotic pathways
Tau pathology: Impaired lysosomal function affects tau degradation, contributing to neurofibrillary tangle formation
Cholinergic neuron degeneration: LAPTM5 in basal forebrain cholinergic neurons supports their survival; dysfunction contributes to AD-related cholinergic loss
In Parkinson's disease, LAPTM5 has protective functions:
Alpha-synuclein clearance: Enhanced LAPTM5 expression promotes lysosomal degradation of alpha-synuclein aggregates[3]
Mitophagy regulation: Supports PINK1/Parkin-mediated mitophagy essential for dopaminergic neuron survival
Neuroinflammation modulation: Alters microglial lysosomal function, affecting neuroinflammatory responses in PD
LAPTM5 is implicated in ALS through:
LAPTM5 represents a promising therapeutic target:
The study of Laptm5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.